A case of platelet transfusion refractoriness due to anti-CD36 with a successful treatment outcome
By:
Paid access
|Feb 2020References
- Lochowicz AJ, Curtis BR. Clinical applications of platelet antibody and antigen testing. Lab Med 2011;42:687–92.
- Ikeda H, Mitani T, Ohnuma M, et al. A new PLT-specific antigen, Naka, involved in the refractoriness of HLA-matched PLT transfusion. Vox Sang 1989;57:213–7.
- Curtis BR, Aster RH. Incidence of the Naka-negative PLT phenotype in African Americans is similar to that of Asians. Transfusion 1996;36:331–4.
- Lee K, Godeau B, Fromont P, et al. CD36 deficiency is frequent and can cause PLT immunization in Africans. Transfusion 1999;39:873–9.
- Yanai H, Chiba H, Fujiwara H, et al. Phenotype-genotype correlation in CD36 deficiency types I and II. Thromb Haemost 2000;84:436–41.
- Li R, Qiao Z, Ling B, Lu P, Zhu Z. Incidence and molecular basis of CD36 deficiency in Shanghai population. Transfusion 2015;55:666–73.
- Metzner K, Bauer J, Ponzi H, Ujcich A, Curtis BR. Detection and identification of PLT antibodies using a sensitive multiplex assay system: PLT antibody bead array (PABA). Transfusion 2017;57:1724–33.
- Yamamoto N, Ikeda H, Tandon NN, et al. A PLT membraneglycoprotein (GP) deficiency in healthy blood donors: Naka-PLTs lack detectable GPIV (CD36). Blood 1990;76:1698–703.
- Curtis BR, Ali S, Glazier AM, Ebert DD, Aitman TJ, Aster RH. Isoimmunization against CD36 (glycoprotein IV): description of four cases of neonatal isoimmune thrombocytopenia and brief review of the literature. Transfusion 2002;42:1173–9.
- Okajima S, Cho K, Chiba H, et al. Two sibling cases of hydrops fetalis due to alloimmune anti-CD36 (Nak a) antibody. Thromb Haemost 2006;95:267–71.
- Chilongola J, Balthazary S, Mpina M, Mhando M, Mbugi E. CD36 deficiency protects against malarial anaemia in children by reducing Plasmodium falciparum-infected red blood cell adherence to vascular endothelium. Trop Med Int Health 2009;14:810–6.
- Hirano K, Kuwasako T, Nakagawa-Toyama Y, Janabi M, Yamashita S, Matsuzawa Y. Pathophysiology of human genetic CD36 deficiency. Trends Cardiovasc Med 2003;13:136–41.
- Furuhashi M, Ura N, Nakata T, Tanaka T, Shimamoto K. Genotype in human CD36 deficiency and diabetes mellitus. Diabet Med 2004;21:952–3.
- Love-Gregory L, Sherva R, Sun L, et al. Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol. Hum Mol Genet 2008;17:1695–704.
- Saw CL, Szykoluk H, Curtis BR, et al. Two cases of PLT transfusion refractoriness associated with anti-CD36. Transfusion 2010;50:2638–42.
- Xia W, Ye X, Xu X, et al. Two cases of PLT transfusion refractoriness and one case of possible FNAIT caused by antibodies against CD36 in China. Transfus Med 2014;24: 254–6.
- Xu X, Li L, Xia W, et al. Successful management of a hydropic fetus with severe anemia and thrombocytopenia caused by anti-CD36 antibody. Int J Hematol 2018;107:251–6.
- Galeotti C, Kaveri SV, Bayry J. IVIG-mediated effector functions in autoimmune and inflammatory diseases. Int Immunol 2017;29:491–8.
- Maloney DG, Grillo-Lopez AJ, White CA, et al. IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin’s lymphoma. Blood 1997;90:2188–95.
- Kneitz C, Wilhelm M, Tony HP. Effective B cell depletion with rituximab in the treatment of autoimmune diseases. Immunobiology 2002;206:519–27.
- Egawa H, Teramukai S, Haga H, Tanabe T, Fukushima M, Shimazu M. Present status of ABO-incompatible living donor liver transplantation in Japan. Hepatology 2008;47143–52.
- Cid J, Magnano L, Acosta M, Alba C, Esteve J, Lozano M. Rituximab, plasma exchange and intravenous immunoglobulins as a new treatment strategy for severe HLA alloimmune platelet refractoriness. Platelets 2015;26:190–4.
- Kornor H, Hammerstrom KT, Brurberg KG, Klemp Gjertsen M, Froland S, Eds. Immunomodulatory treatments with intravenous immunoglobulin. Report from Norwegian Knowledge Centre for the Health Services (NOKC), no. 14–2008. NIPH systematic reviews: executive summaries. Oslo, Norway: Knowledge Centre for the Health Services, The Norwegian Institute of Public Health (NIPH); 2008.
- Winkelhorst D, Oepkes D, Lopriore E. Fetal and neonatal alloimmune thrombocytopenia: evidence based antenatal and postnatal management strategies. Expert Rev Hematol 2017;10:729–37.
- Taketani T, Ito K, Mishima S, et al. Neonatal isoimmune thrombocytopenia caused by type I CD36 deficiency having novel splicing isoforms of the CD36 gene. Eur J Haematol 2008;81:70–4.
- Bierling P, Godeau B, Fromont P, et al. Posttransfusion purpura-like syndrome associated with CD36 (Naka) isoimmunization. Transfusion 1995;35:777–82.
DOI: https://doi.org/10.21307/immunohematology-2020-028 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 139 - 144
Published on: Feb 16, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Related subjects:
© 2020 S.S. Khatri, B.R Curtis, C. Yamada, published by American National Red Cross
This work is licensed under the Creative Commons License.